Appropriately inhibiting the expression of AP-1 can effectively alleviate the cardiovascular toxicity caused by various factors, such as intimal hyperplasia, myocardial hypertrophy, hypertension, and myocardial fibrosis [37–39]. The gene discussed is JUN; the disease is hypertensive disorder.